Human IL25/IL17E ORF/cDNA clone-Lentivirus particle (NM_022789)
Cat. No.: vGMLP-IL-032
Pre-made Human IL25/IL17E Lentiviral expression plasmid for IL25 lentivirus packaging, IL25 lentivirus production, overexpression stable cell line development, cell transient transfection and gene delivery targeting T/B/NK cells, macrophages, cardiomyocytes, hepatocytes, and neurons.
The GM Vector Core (GMVC) specializes in custom lentivirus development and offers a range of lentivirus manufacturing solutions, leveraging state-of-the-art processes. Learn more about our services.
Go to
IL25/IL17E products
collection>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
| Catalog No. | Product Name | lentivirus Grade | lentivirus quantity |
|---|---|---|---|
| vGMLP-IL-032 | Human IL25 Lentivirus particle | Pilot Grade | 1.0E+8TU |
| 5.0E+8TU | |||
| 1.0E+9TU | |||
| Research Grade | 1.0E+8TU | ||
| 5.0E+8TU | |||
| 1.0E+9TU | |||
| GMP-like Grade | inquiry | ||
| GMP Grade | inquiry |
Product Description
| Catalog ID | vGMLP-IL-032 |
| Gene Name | IL25 |
| Accession Number | NM_022789 |
| Gene ID | 64806 |
| Species | Human |
| Product Type | Lentivirus particle (overexpression) |
| Insert Length | 534 bp |
| Gene Alias | IL17E |
| Fluorescent Reporter | ZsGreen |
| Mammalian Cell Selection | Puromyocin |
| Fusion Tag | 3xflag (C-Terminal) |
| Promoter | CMV |
| Resistance | Amplicin |
| ORF Nucleotide Sequence | ATGAGGGAGCGACCCAGATTAGGTGAGGACAGTTCTCTCATTAGCCTTTTCCTACAGGTGGTTGCATTCTTGGCAATGGTCATGGGAACCCACACCTACAGCCACTGGCCCAGCTGCTGCCCCAGCAAAGGGCAGGACACCTCTGAGGAGCTGCTGAGGTGGAGCACTGTGCCTGTGCCTCCCCTAGAGCCTGCTAGGCCCAACCGCCACCCAGAGTCCTGTAGGGCCAGTGAAGATGGACCCCTCAACAGCAGGGCCATCTCCCCCTGGAGATATGAGTTGGACAGAGACTTGAACCGGCTCCCCCAGGACCTGTACCACGCCCGTTGCCTGTGCCCGCACTGCGTCAGCCTACAGACAGGCTCCCACATGGACCCCCGGGGCAACTCGGAGCTGCTCTACCACAACCAGACTGTCTTCTACCGGCGGCCATGCCATGGCGAGAAGGGCACCCACAAGGGCTACTGCCTGGAGCGCAGGCTGTACCGTGTTTCCTTAGCTTGTGTGTGTGTGCGGCCCCGTGTGATGGGCTAG |
| ORF Protein Sequence | MRERPRLGEDSSLISLFLQVVAFLAMVMGTHTYSHWPSCCPSKGQDTSEELLRWSTVPVPPLEPARPNRHPESCRASEDGPLNSRAISPWRYELDRDLNRLPQDLYHARCLCPHCVSLQTGSHMDPRGNSELLYHNQTVFYRRPCHGEKGTHKGYCLERRLYRVSLACVCVRPRVMG |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
| Category | Cat No. | Products Name |
|---|---|---|
| Target Antibody | GM-Tg-g-T62241-Ab | Anti-IL25/ IL17E functional antibody |
| Target Antigen | GM-Tg-g-T62241-Ag | IL25 protein |
| Cytokine | cks-Tg-g-GM-T62241 | Interleukin 25 (IL25) protein & antibody |
| ORF Viral Vector | pGMAP000371 | Human IL25 Adenovirus plasmid |
| ORF Viral Vector | pGMLP-IL-032 | Human IL25 Lentivirus plasmid |
| ORF Viral Vector | pGMAP-IL-115 | Human IL25 Adenovirus plasmid |
| ORF Viral Vector | vGMAP000371 | Human IL25 Adenovirus particle |
| ORF Viral Vector | vGMLP-IL-032 | Human IL25 Lentivirus particle |
| ORF Viral Vector | vGMAP-IL-115 | Human IL25 Adenovirus particle |
Target information
| Target ID | GM-T62241 |
| Target Name | IL25 |
|
Gene Group Identifier (Target Gene ID in Homo species) |
64806 |
| Gene ID |
101095746 (Felis catus), 111768801 (Equus caballus), 140806 (Mus musculus), 480252 (Canis lupus familiaris) 501996 (Rattus norvegicus), 526816 (Bos taurus), 64806 (Homo sapiens), 713943 (Macaca mulatta) |
| Gene Symbols & Synonyms | IL25,Il25,IL-25,Il17e,IL-17e,RGD1561632,IL17E |
| Target Alternative Names | IL-17e,IL-25,IL17E,IL25,Il17e,Il25,Interleukin-17E (IL-17E),Interleukin-25,RGD1561632 |
| Uniprot Accession |
Q8VHH8,Q9H293
Additional SwissProt Accessions: Q8VHH8,Q9H293 |
| Uniprot Entry Name | |
| Protein Sub-location | Secreted Protein/Potential Cytokines |
| Category | Therapeutics Target, Cytokine Target |
| Disease | |
| Disease from KEGG | Cytokine-cytokine receptor interaction, IL-17 signaling pathway |
| Gene Ensembl | ENSMUSG00000040770, ENSCAFG00845003612, ENSBTAG00000009701, ENSG00000166090 |
| Target Classification |
About GMVC

GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.


